Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002028357 | SCV002283561 | uncertain significance | Jeune thoracic dystrophy; Nephronophthisis | 2021-09-24 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. This variant has not been reported in the literature in individuals affected with TTC21B-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change replaces serine with leucine at codon 3 of the TTC21B protein (p.Ser3Leu). The serine residue is moderately conserved and there is a large physicochemical difference between serine and leucine. |
Fulgent Genetics, |
RCV002479709 | SCV002785057 | uncertain significance | Asphyxiating thoracic dystrophy 4; Nephronophthisis 12 | 2021-12-12 | criteria provided, single submitter | clinical testing |